# Viking Therapeutics
 (stock symbol: VKTX) Logo in transparent PNG and SVG formats

## Viking Therapeutics
 Logo large

### Viking Therapeutics
 Logo large Download PNG (40.32 KB)

![Viking Therapeutics
 Logo large Download PNG (40.32 KB)](/img/orig/VKTX_BIG-f51ad7dd.png)

### Viking Therapeutics
 Logo large Download SVG (5.43 KB)

![Viking Therapeutics
 Logo large Download SVG (5.43 KB)](/img/orig/VKTX_BIG-8e43de76.svg)

## Viking Therapeutics
 Logo icon format

### Viking Therapeutics
 Logo icon format Download PNG (26.83 KB)

![Viking Therapeutics
 Logo icon format Download PNG (26.83 KB)](/img/orig/VKTX-b81eec31.png)

### Viking Therapeutics
 Logo icon format Download SVG (744 Bytes)

![Viking Therapeutics
 Logo icon format Download SVG (744 Bytes)](/img/orig/VKTX-7497fa4b.svg)

## About Viking Therapeutics


Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRÃŸ), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, an orally available Phase IIb-ready drug candidate for type 2 diabetes; and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRÃŸ for X-linked adrenoleukodystrophy. The company was incorporated in 2012 and is headquartered in San Diego, California.

1. Website domain: vikingtherapeutics.com
2. Employees: 16
3. Marketcap: $2.09 Billion USD


## Categories
- [x] ðŸ‡ºðŸ‡¸ United States
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
